TY - JOUR
T1 - Knowledge, attitude, and practice outcomes: Evaluating the impact of counseling in hospitalized diabetic patients in India
AU - Palaian, S.
AU - Acharya, L.D.
AU - Rao, P.G.M.
AU - Shankar, P.R.
AU - Nair, N.M.
AU - Nair, N.P.
N1 - Cited By :11
Export Date: 10 November 2017
CODEN: PPTTE
Correspondence Address: Palaian, S.; Manipal Teaching Hospital, Manipal College of Medical Sciences, Pokhara, Nepal
Chemicals/CAS: acarbose, 56180-94-0; glibenclamide, 10238-21-8; glucose, 50-99-7, 84778-64-3; insulin, 9004-10-8; metformin, 1115-70-4, 657-24-9; pioglitazone, 105355-27-9, 111025-46-8
Tradenames: actos, Lilly; actos, Takeda; glucophage, Bristol Myers Squibb; precose, Bayer
Manufacturers: Bayer; Bristol Myers Squibb; Lilly; Takeda
References: Anderson-Harper, H.M., Berger, B.A., Noel, R., Pharmacists' predisposition to communicate, desire to counsel, and job satisfaction (1992) Am J Pharm Educ, 56, pp. 252-258; Pharmacy communication (1986) Hospital Pharmacy, 5th Ed., pp. 154-159. , Hassan WE, ed. Philadelphia: Lea & Febiger; Popovich, N.G., Ambulatory patient care (1995) Remington: The Science and Practice of Pharmacy, 19th Ed., pp. 1695-1719. , Gennaro AR, ed. Easton, PA: Mack Publishing; Jepson, M.H., Patient compliance and counseling (1990) Pharmaceutical Practice, pp. 346-349. , Collet DM, Aulton ME, eds. Edinburgh: Churchill Livingstone; Dooley, M., Lyall, H., Galbriath, K., SHPA standards of practice for clinical pharmacy (1996) Practice Standards and Definitions, pp. 2-11. , Society of Hospital Pharmacists of Australia (SHPA); Omnibus Budget Reconciliation Act of 1990, Pub. L. No. 101-508, and 4401, 104 stat 1388, 1990; ASHP guidelines on pharmacist-conducted patient counseling (1976) Am J Hosp Pharm, 33, pp. 644-645; Diabetes Statistics, , www.diabetes.org/diabetes-statistics.jsp; Kapur, A., Shishoo, S., Ahuja, M.M.S., Diabetes care in India: Physicians' perceptions attitudes and practices (DIAPP-2 study) (1998) Int J Diabetes Dev Countries, 18, pp. 124-130; Cantrill, J.A., Wood, J., Diabetes mellitus (1999) Clinical Pharmacy and Therapeutics, 3rd Ed., pp. 657-677. , Walker R, Edwards CRW, eds. Edinburgh: Churchill Livingstone; Coons, S.J., Health outcomes and quality of life (1999) Pharmacotherapy: A Pathophysiological Approach, 4th Ed., pp. 12-20. , DiPiro JT, Talbert RL, Yee GC, eds. Norwalk, CT: Appleton & Lange; Diabetes mellitus and exercise (1997) Diabetes Care, 20, pp. 1908-1912; The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus (1993) N Engl J Med, 329, pp. 977-986; Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (1998) Lancet, 352, pp. 837-853; Jaber, L.A., Halapy, H., Fernet, M., Evaluation of pharmaceutical care model on diabetes management (1996) Ann Pharmacother, 30, pp. 238-242; Rasheed, A., Ramesh, A., Nagavi, B.G., Improvement in quality of life through patient counseling (2002) Pharma Times, 34, pp. 9-10; Lewis, R.K., Lasack, N.L., Lambert, B.L., Patient counseling: A focus on maintenance therapy (1997) Am J Health Syst Pharm, 54, pp. 2084-2095; Setter, S.M., White, J.R., Campbell, R.K., Diabetes (2000) Textbook of Therapeutics: Drug and Disease Management, 7th Ed., pp. 377-406. , Herfindal ET, Gourley DR, eds. Philadelphia: Lippincott Williams & Wilkins; Expert Panel on the Management of Asthma: Patient education (1991) J Allergy Clin Immunol, 88, pp. 460-472; Hawkins, D.W., Fiedler, F.P., Dougles, H.L., Eschbach, R.C., Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients (1979) Am J Hosp Pharm, 36, pp. 1321-1325; Oki, J.C., Isley, W.L., Diabetes mellitus (2002) Pharmacotherapy: A Pathophysiological Approach, 5th Ed., pp. 1335-1358. , DiPiro JT, Talbert RL, Yee GC, eds. Stamford, CT: Appleton & Lange; Schilling, K.W., Pharmacy program for monitoring diabetic patients (1977) Am J Hosp Pharm, 34, pp. 1242-1245; Sczupak, C.A., Conrad, W.F., Relationship between patient-oriented pharmaceutical services and therapeutic outcomes of ambulatory patients with diabetes mellitus (1977) Am J Hosp Pharm, 34, pp. 1238-1242; Kaeter, A.J., Ferrara, A., Darbinian, J.A., Self-monitoring of diabetes (2000) Diabetes Care, 23, pp. 477-483; Sivagnanam, G., Namasivayam, K., Rajasekaran, M., A comparative study of the knowledge, beliefs, and practices of diabetic patients cared for at a teaching hospital (free service) and those cared for by private practitioners (paid service) (2002) Ann NY Acad Sci, 958, pp. 416-419; Raisch, D.W., Barriers to providing cognitive services (1993) Am Pharm, 33, pp. 54-58
PY - 2006
Y1 - 2006
N2 - Background. Patient involvement forms the cornerstone of the management of chronic diseases such as diabetes mellitus. Objective. We evaluated the results of counseling selected hospitalized diabetic patients about their medications, disease, and lifestyle modifications in terms of knowledge, attitude, and practice outcomes. Methods. Diabetic patients were counseled via regular bedside meetings, via the distribution of leaflets throughout their hospital stay, and during regular follow-up visits for two months after discharge from the hospital. Results. Forty-six patients (19 in the test group and 27 controls) completed the study. In the test group, 12 patients (63.1%) were counseled in Kannada, the local language of the study site. A total of 30 to 60 minutes was spent in counseling 63.1% of the patients. Insulin was explained to 13 patients (68.4%); among the oral antidiabetic agents, metformin was discussed with 10 (52.6%) of the 19 patients. Although knowledge scores in the test group of patients improved, compared with those of the control group, as determined by the Mann-Whitney test (P <.05), we did not observe significant improvement in attitude or practice outcomes. Conclusion. Patient counseling by a clinical pharmacist improved knowledge scores, but this improved knowledge did not lead to appropriate attitudes or practices.
AB - Background. Patient involvement forms the cornerstone of the management of chronic diseases such as diabetes mellitus. Objective. We evaluated the results of counseling selected hospitalized diabetic patients about their medications, disease, and lifestyle modifications in terms of knowledge, attitude, and practice outcomes. Methods. Diabetic patients were counseled via regular bedside meetings, via the distribution of leaflets throughout their hospital stay, and during regular follow-up visits for two months after discharge from the hospital. Results. Forty-six patients (19 in the test group and 27 controls) completed the study. In the test group, 12 patients (63.1%) were counseled in Kannada, the local language of the study site. A total of 30 to 60 minutes was spent in counseling 63.1% of the patients. Insulin was explained to 13 patients (68.4%); among the oral antidiabetic agents, metformin was discussed with 10 (52.6%) of the 19 patients. Although knowledge scores in the test group of patients improved, compared with those of the control group, as determined by the Mann-Whitney test (P <.05), we did not observe significant improvement in attitude or practice outcomes. Conclusion. Patient counseling by a clinical pharmacist improved knowledge scores, but this improved knowledge did not lead to appropriate attitudes or practices.
M3 - Article
SN - 1052-1372
VL - 31
SP - 383
EP - 392
JO - P and T
JF - P and T
IS - 7
ER -